LabGenius is a leading machine learning-driven protein engineering company pioneering the discovery of next-generation therapeutics. The company’s discovery platform, EVATM, integrates several bleeding-edge technologies drawn from the fields of machine learning, robotic automation and synthetic biology. Headquartered in London, UK, the LabGenius team includes experts in protein engineering, synthetic biology, software engineering, data science and robotic automation.